---
title: "EMBLOK enrols 50th patient in TAVR embolic protection trial"
date: "2024-10-08T15:57:31.000Z"
publishedDate: "8 octobre 2024"
summary: "EMBLOK has announced that it has enrolled the first 50 patients in a clinical trial to evaluate the performance and treatment effect of its Emblok embolic protection system (EPS). Explosive growth in transcatheter aortic valve replacement (TAVR) volumes has been reported globally, with some growth rates &#62;50-fold according to a report from the American Heart [&#8230;] The post EMBLOK enrols 50th patient in TAVR embolic protection trial appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/emblok-enrols-50th-patient-in-tavr-embolic-protection-trial/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-10-08-emblok-enrols-50th-patient-in-tavr-embolic-protection-trial"
imageUrl: "http://interventionalnews.com/wp-content/uploads/sites/13/2024/10/Emblok_EPS.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/emblok-enrols-50th-patient-in-tavr-embolic-protection-trial/"
---

![EMBLOK enrols 50th patient in TAVR embolic protection trial](http://interventionalnews.com/wp-content/uploads/sites/13/2024/10/Emblok_EPS.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/emblok-enrols-50th-patient-in-tavr-embolic-protection-trial/*

## L’essentiel

EMBLOK has announced that it has enrolled the first 50 patients in a clinical trial to evaluate the performance and treatment effect of its Emblok embolic protection system (EPS). Explosive growth in transcatheter aortic valve replacement (TAVR) volumes has been reported globally, with some growth rates &#62;50-fold according to a report from the American Heart [&#8230;] The post EMBLOK enrols 50th patient in TAVR embolic protection trial appeared first on Interventional News .

## Lien source

https://interventionalnews.com/emblok-enrols-50th-patient-in-tavr-embolic-protection-trial/
